schizandrer a has been researched along with oxidopamine in 1 studies
| Studies (schizandrer a) | Trials (schizandrer a) | Recent Studies (post-2010) (schizandrer a) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 65 | 0 | 52 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | schizandrer a (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, SW; Chang, RC; Chong, CM; Hoi, PM; Sa, F; Wang, Y; Yuen Lee, SM; Zhang, LQ; Zhou, ZY | 1 |
1 other study(ies) available for schizandrer a and oxidopamine
| Article | Year |
|---|---|
Schisantherin A protects against 6-OHDA-induced dopaminergic neuron damage in zebrafish and cytotoxicity in SH-SY5Y cells through the ROS/NO and AKT/GSK3β pathways.
Topics: Animals; Antiparkinson Agents; Cell Line, Tumor; Cyclooctanes; Dioxoles; Dopaminergic Neurons; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lignans; Neuroblastoma; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Oxidopamine; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Schisandra; Signal Transduction; Zebrafish | 2015 |